Migraine: preventive treatment

被引:180
|
作者
Silberstein, SD
Goadsby, PJ
机构
[1] Thomas Jefferson Univ Hosp, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[2] UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, London WC1N 3BG, England
关键词
migraine; prevention; treatment; prophylaxis;
D O I
10.1046/j.1468-2982.2002.00386.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine is a common episodic headache disorder. A comprehensive headache treatment plan includes acute attack treatment to relieve pain and impairment and long-term preventive therapy to reduce attack frequency, severity, and duration. Circumstances that might warrant preventive treatment include: (i) migraine that significantly interferes with the patient's daily routine despite acute treatment; (ii) failure, contraindication to, or troublesome side-effects from acute medications; (iii) overuse of acute medications; (iv) special circumstances, such as hemiplegic migraine; (v) very frequent headaches (more than two a week); or (vi) patient preference. Start the drug at a low dose. Give each treatment an adequate trial. Avoid interfering, overused, and contraindicated drugs. Re-evaluate therapy. Be sure that a woman of childbearing potential is aware of any potential risks. Involve patients in their care to maximize compliance. Consider co-morbidity. Choose a drug based on its proven efficacy, the patient's preferences and headache profile, the drug's side-effects, and the presence or absence of coexisting or co-morbid disease. Drugs that have documented high efficacy and mild to moderate adverse events (AEs) include beta-blockers, amitriptyline, and divalproex. Drugs that have lower documented efficacy and mild to moderate AEs include selective serotonin reuptake inhibitors (SSRIs), calcium channel antagonists, gabapentin, topiramate, riboflavin, and non-steroidal anti-inflammatory drugs.
引用
收藏
页码:491 / 512
页数:22
相关论文
共 50 条
  • [41] Subcutaneous histamine for preventive treatment of migraine? Response
    Millan Guerrero, R.
    NEUROLOGIA, 2006, 21 (08): : 452 - 453
  • [42] Preventive Treatment for Patients With Migraine and Cardiovascular Disease
    Panesar, Kiran
    US PHARMACIST, 2018, 43 (12) : 38 - 44
  • [43] Feverfew as a preventive treatment for migraine: a systematic review
    Vogler, BK
    Pittler, MH
    Ernst, E
    CEPHALALGIA, 1998, 18 (10) : 704 - 708
  • [44] Alternatives to beta blockers in preventive migraine treatment
    Evers, S.
    NERVENARZT, 2008, 79 (10): : 1135 - +
  • [45] Naratriptan in the preventive treatment of refractory chronic migraine
    Rapoport, A
    Bigal, M
    Sheftell, F
    Volcy, M
    Feleppa, M
    Tepper, S
    CEPHALALGIA, 2003, 23 (07) : 751 - 751
  • [46] Effectiveness and safety of gabapentin in the preventive treatment of migraine
    Jiménez-Hernández, MD
    Torrecillas-Narváez, MD
    Friera-Acebal, G
    REVISTA DE NEUROLOGIA, 2002, 35 (07) : 603 - 606
  • [47] Preventive treatment in migraine and the new US guidelines
    Estemalik, E.
    Tepper, S.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 709 - 720
  • [48] Advances in the Acute and Preventive Treatment of Pediatric Migraine
    Rastogi, Reena Gogia
    Hastriter, Eric Vance
    Evans, Rachel L.
    Bassal, Frederick
    Hickman, Carolyn
    Karnik, Kavitha T.
    Little, Robert
    Lewis, Kara Stuart
    CURRENT PAIN AND HEADACHE REPORTS, 2023, 27 (10) : 521 - 529
  • [49] Preventive treatment of migraine with vasobral: a multicenter trial
    Tabeeva, G. R.
    Azimova, Yu. E.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (11) : 26 - 30
  • [50] Advances in the Acute and Preventive Treatment of Pediatric Migraine
    Reena Gogia Rastogi
    Eric Vance Hastriter
    Rachel L. Evans
    Frederick Bassal
    Carolyn Hickman
    Kavitha T. Karnik
    Robert Little
    Kara Stuart Lewis
    Current Pain and Headache Reports, 2023, 27 : 521 - 529